Article
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
Vaccine - 5 Apr 2006
Engel Amber R, Vasconcelos Pedro F C, McArthur Monica A, Barrett Alan D T
Abstract excerpt
Although the live attenuated yellow fever (YF) 17D vaccine is considered to be one of the safest vaccines in the world today, several cases of disease associated with administration of the vaccine have been reported, including YF vaccine-associated viscerotropic disease (YF-VAVD), which was first described in 1996. All YF-VAVD isolates sequenced to date have shown very little genomic change when compared to their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.